$COLL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in COLLEGIUM PHARMACEUTICAL, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in COLLEGIUM PHARMACEUTICAL, INC. Get notifications about new insider transactions in COLLEGIUM PHARMACEUTICAL, INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 25 2017 | COLL | COLLEGIUM PHARMACE ... | Fallon John A. | Director | Option Exercise | A | 9.33 | 19,853 | 185,228 | 19,853 | |
May 25 2017 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | A | 9.33 | 19,853 | 185,228 | 19,853 | |
May 25 2017 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 9.33 | 19,853 | 185,228 | 19,853 | |
May 15 2017 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Buy | P | 9.18 | 10,000 | 91,800 | 110,227 | 100.2 K to 110.2 K (+9.98 %) |
Mar 21 2017 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Payment of Exercise | F | 14.95 | 1,472 | 22,006 | 609,083 | 610.6 K to 609.1 K (-0.24 %) |
Mar 21 2017 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 14.95 | 388 | 5,801 | 100,227 | 100.6 K to 100.2 K (-0.39 %) |
Mar 21 2017 | COLL | COLLEGIUM PHARMACE ... | Duke Barry S | See remarks | Payment of Exercise | F | 14.95 | 388 | 5,801 | 20,087 | 20.5 K to 20.1 K (-1.89 %) |
Mar 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 14.95 | 388 | 5,801 | 24,313 | 24.7 K to 24.3 K (-1.57 %) |
Feb 02 2017 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Option Exercise | M | 0.48 | 3,013 | 1,446 | 0 | |
Feb 02 2017 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Buy | M | 0.48 | 3,013 | 1,446 | 555,555 | 552.5 K to 555.6 K (+0.55 %) |
Feb 02 2017 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Grant | A | 10.08 | 1,239 | 12,489 | 552,542 | 551.3 K to 552.5 K (+0.22 %) |
Aug 15 2016 | COLL | COLLEGIUM PHARMACE ... | Fallon John A. | Director | Buy | P | 10.59 | 2,375 | 25,151 | 2,375 | 0 to 2.4 K |
Aug 03 2016 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Grant | A | 10.31 | 1,212 | 12,496 | 551,303 | 550.1 K to 551.3 K (+0.22 %) |
Aug 03 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 10.31 | 983 | 10,135 | 83,359 | 82.4 K to 83.4 K (+1.19 %) |
Aug 03 2016 | COLL | COLLEGIUM PHARMACE ... | Duke Barry S | See remarks | Grant | A | 10.31 | 978 | 10,083 | 5,891 | 4.9 K to 5.9 K (+19.91 %) |
Jun 13 2016 | COLL | COLLEGIUM PHARMACE ... | Fallon John A. | Director | Option Exercise | A | 16.49 | 15,000 | 247,350 | 15,000 | |
Jun 13 2016 | COLL | COLLEGIUM PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 16.49 | 8,700 | 143,463 | 8,700 | |
Jun 13 2016 | COLL | COLLEGIUM PHARMACE ... | Nadav Eran | Director | Option Exercise | A | 16.49 | 8,700 | 143,463 | 8,700 | |
Jun 13 2016 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 16.49 | 8,700 | 143,463 | 8,700 | |
Jun 13 2016 | COLL | COLLEGIUM PHARMACE ... | BOHLIN GAREN G | Director | Option Exercise | A | 16.49 | 8,700 | 143,463 | 8,700 | |
Jun 13 2016 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 16.49 | 8,700 | 143,463 | 8,700 | |
Jun 13 2016 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | A | 16.49 | 8,700 | 143,463 | 8,700 | |
May 23 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 16.89 | 1,100 | 18,579 | 82,376 | 81.3 K to 82.4 K (+1.35 %) |
May 19 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 16.00 | 900 | 14,400 | 81,276 | 80.4 K to 81.3 K (+1.12 %) |
May 18 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 15.46 | 1,000 | 15,460 | 80,376 | 79.4 K to 80.4 K (+1.26 %) |
May 16 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 15.73 | 800 | 12,584 | 79,376 | 78.6 K to 79.4 K (+1.02 %) |
May 13 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 15.02 | 1,200 | 18,024 | 78,576 | 77.4 K to 78.6 K (+1.55 %) |
Apr 07 2016 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Option Exercise | M | 0.48 | 3,931 | 1,887 | 3,013 | |
Apr 07 2016 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Option Exercise | M | 3.31 | 9,673 | 32,018 | 0 | |
Apr 07 2016 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Buy | M | 0.48 | 3,931 | 1,887 | 387,048 | 383.1 K to 387 K (+1.03 %) |
Apr 07 2016 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Buy | M | 3.31 | 9,673 | 32,018 | 383,117 | 373.4 K to 383.1 K (+2.59 %) |
Jan 26 2016 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 17.06 | 15,000 | 255,900 | 15,000 | |
Jan 22 2016 | COLL | COLLEGIUM PHARMACE ... | Duke Barry S | See remarks | Option Exercise | A | 16.15 | 29,475 | 476,021 | 29,475 | |
Jan 22 2016 | COLL | COLLEGIUM PHARMACE ... | Duke Barry S | See remarks | Grant | A | 0.00 | 4,913 | 0 | 4,913 | 0 to 4.9 K |
Jan 22 2016 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Option Exercise | A | 16.15 | 109,005 | 1,760,431 | 109,005 | |
Jan 22 2016 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Grant | A | 0.00 | 18,135 | 0 | 373,444 | 355.3 K to 373.4 K (+5.10 %) |
Jan 22 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 16.15 | 29,475 | 476,021 | 29,475 | |
Jan 22 2016 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 4,913 | 0 | 77,376 | 72.5 K to 77.4 K (+6.78 %) |
Sep 14 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | A | 13.45 | 15,000 | 201,750 | 15,000 | |
Sep 14 2015 | COLL | COLLEGIUM PHARMACE ... | Nadav Eran | Director | Option Exercise | A | 13.45 | 15,000 | 201,750 | 15,000 | |
Sep 14 2015 | COLL | COLLEGIUM PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 13.45 | 15,000 | 201,750 | 15,000 | |
Sep 14 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 13.45 | 15,000 | 201,750 | 15,000 | |
Sep 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Option Exercise | A | 13.45 | 15,000 | 201,750 | 15,000 | |
May 18 2015 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Option Exercise | A | 14.90 | 70,193 | 1,045,876 | 70,193 | |
May 18 2015 | COLL | COLLEGIUM PHARMACE ... | Duke Barry S | See remarks | Option Exercise | A | 14.90 | 27,537 | 410,301 | 27,537 | |
May 18 2015 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 14.90 | 22,929 | 341,642 | 22,929 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 3,676,078 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 2,705,585 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 1,533,399 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 4,019,183 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Buy | P | 12.00 | 150,000 | 1,800,000 | 1,887,332 | 1.7 M to 1.9 M (+8.63 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Buy | C | 0.00 | 540,498 | 0 | 1,737,332 | 1.2 M to 1.7 M (+45.16 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Buy | C | 0.00 | 392,113 | 0 | 1,196,834 | 804.7 K to 1.2 M (+48.73 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Buy | C | 0.00 | 222,231 | 0 | 804,721 | 582.5 K to 804.7 K (+38.15 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Heron Patrick J | Director | Buy | C | 0.00 | 582,490 | 0 | 582,490 | 0 to 582.5 K |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Frazier Healthcare VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,676,078 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Frazier Healthcare VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,705,585 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Frazier Healthcare VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,533,399 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Frazier Healthcare VI, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,019,183 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Frazier Healthcare VI, L.P. | 10% Owner | Buy | P | 12.00 | 150,000 | 1,800,000 | 1,887,332 | 1.7 M to 1.9 M (+8.63 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Frazier Healthcare VI, L.P. | 10% Owner | Buy | C | 0.00 | 540,498 | 0 | 1,737,332 | 1.2 M to 1.7 M (+45.16 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Frazier Healthcare VI, L.P. | 10% Owner | Buy | C | 0.00 | 392,113 | 0 | 1,196,834 | 804.7 K to 1.2 M (+48.73 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Frazier Healthcare VI, L.P. | 10% Owner | Buy | C | 0.00 | 222,231 | 0 | 804,721 | 582.5 K to 804.7 K (+38.15 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Frazier Healthcare VI, L.P. | 10% Owner | Buy | C | 0.00 | 582,490 | 0 | 582,490 | 0 to 582.5 K |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Option Exercise | C | 0.00 | 101,128 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Option Exercise | C | 0.00 | 5,045,381 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Option Exercise | C | 0.00 | 63,356 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Option Exercise | C | 0.00 | 3,160,905 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Option Exercise | C | 0.00 | 257,303 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Option Exercise | C | 0.00 | 12,837,935 | 0 | 0 | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Buy | P | 12.00 | 3,930 | 47,160 | 65,270 | 61.3 K to 65.3 K (+6.41 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Buy | C | 0.00 | 61,340 | 0 | 61,340 | 0 to 61.3 K |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Buy | P | 12.00 | 196,070 | 2,352,840 | 3,256,572 | 3.1 M to 3.3 M (+6.41 %) |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Buy | C | 0.00 | 3,060,502 | 0 | 3,060,502 | 0 to 3.1 M |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | TPG Group Holdings (SBS) Advis ... | Option Exercise | C | 0.00 | 8,333,333 | 0 | 0 | ||
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | TPG Group Holdings (SBS) Advis ... | Buy | P | 12.00 | 100,000 | 1,200,000 | 1,325,253 | 1.2 M to 1.3 M (+8.16 %) | |
May 14 2015 | COLL | COLLEGIUM PHARMACE ... | TPG Group Holdings (SBS) Advis ... | Buy | C | 0.00 | 1,207,729 | 0 | 1,225,253 | 17.5 K to 1.2 M (+6,891.86 %) | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Skyline Venture Partners V LP | 10% Owner | Option Exercise | C | 0.00 | 5,881,724 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Skyline Venture Partners V LP | 10% Owner | Option Exercise | C | 0.00 | 2,638,030 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Skyline Venture Partners V LP | 10% Owner | Option Exercise | C | 0.00 | 10,714,286 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Skyline Venture Partners V LP | 10% Owner | Buy | P | 12.00 | 150,000 | 1,800,000 | 2,949,916 | 2.8 M to 2.9 M (+5.36 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Skyline Venture Partners V LP | 10% Owner | Buy | C | 0.00 | 864,798 | 0 | 2,799,916 | 1.9 M to 2.8 M (+44.69 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Skyline Venture Partners V LP | 10% Owner | Buy | C | 0.00 | 382,323 | 0 | 1,935,118 | 1.6 M to 1.9 M (+24.62 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Skyline Venture Partners V LP | 10% Owner | Buy | C | 0.00 | 1,552,795 | 0 | 1,552,795 | 0 to 1.6 M |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | C | 0.00 | 101,128 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | C | 0.00 | 5,045,381 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | C | 0.00 | 63,356 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | C | 0.00 | 3,160,905 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | C | 0.00 | 257,303 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | C | 0.00 | 12,837,935 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Buy | P | 12.00 | 3,930 | 47,160 | 65,270 | 61.3 K to 65.3 K (+6.41 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Buy | C | 0.00 | 14,868 | 0 | 61,340 | 46.5 K to 61.3 K (+31.99 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Buy | C | 0.00 | 9,182 | 0 | 46,472 | 37.3 K to 46.5 K (+24.62 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Buy | C | 0.00 | 37,290 | 0 | 37,290 | 0 to 37.3 K |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Buy | P | 12.00 | 196,070 | 2,352,840 | 3,256,572 | 3.1 M to 3.3 M (+6.41 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Buy | C | 0.00 | 741,830 | 0 | 3,060,502 | 2.3 M to 3.1 M (+31.99 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Buy | C | 0.00 | 458,102 | 0 | 2,318,672 | 1.9 M to 2.3 M (+24.62 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Buy | C | 0.00 | 1,860,570 | 0 | 1,860,750 | 180 to 1.9 M (+1,033,650.00 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 5,881,724 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 2,638,030 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 10,714,286 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | P | 12.00 | 150,000 | 1,800,000 | 2,949,916 | 2.8 M to 2.9 M (+5.36 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | C | 0.00 | 864,798 | 0 | 2,799,916 | 1.9 M to 2.8 M (+44.69 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | C | 0.00 | 382,323 | 0 | 1,935,118 | 1.6 M to 1.9 M (+24.62 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | C | 0.00 | 1,552,795 | 0 | 1,552,795 | 0 to 1.6 M |